small molecule therapy

genome instability and mutation

kinase inhibitors (tyrosine and serine), epigenetic inhibitors (epidrugs), proteosome inhibitors, BCL-2 inhibitors and PARP inhibitors

receptor tyrosine kinase inhibitors and non-receptor tyrosine kinases

<p>growth and apoptosis pathways and CDK inhibitors control cell cycle pathways</p> Signup and view all the answers

<p>block the proteosome pathway responsible for protein degradation and the production of growth-promoting proteins</p> Signup and view all the answers

<p>promote apoptosis</p> Signup and view all the answers

<p>BH3 mimetics</p> Signup and view all the answers

<p>EGFR, VEGFR, Getfitinib</p> Signup and view all the answers

<p>by blobking the activity of tyrosine kinase enzymes which a responsible for pathways involved in cell growth proliferation and survival</p> Signup and view all the answers

<p>in cancer tyrosine kinases are over activated leading to uncontrolled cell growth and tumour progression</p> Signup and view all the answers